4//SEC Filing
Daniels Eric Joseph 4
Accession 0001372514-23-000149
CIK 0001372514other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:48 PM ET
Size
7.7 KB
Accession
0001372514-23-000149
Insider Transaction Report
Form 4
Daniels Eric Joseph
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-09-29+125,000→ 125,000 totalExercise: $0.57From: 2023-09-29Exp: 2033-09-29→ Common Stock (125,000 underlying) - Award
Common Stock
2023-09-29+62,500→ 88,338 total
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001892943
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:48 PM ET
- Size
- 7.7 KB